Search research articles
Contact Us
Filters
Showing results (91-100 of 147) with videos related to
Page
of 15
Sort By:
The Journal of Pediatrics
|
March 23, 2010
Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele
Akira Ohishi, Shigehiro Takahashi, Yushi Ito, et al.
Communications Biology
|
February 13, 2021
Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation
Keisuke Takeda, Aoi Uda, Mikihiro Mitsubori, et al.
Journal of Pediatric Surgery
|
December 1, 2009
Evaluating mortality and disease severity in congenital diaphragmatic hernia using the McGoon and pulmonary artery indices
Shigehiro Takahashi, Yoshihisa Oishi, Naoki Ito, et al.
Plos Currents
|
November 22, 2011
Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages
Bo Wang, Yuko Miyagoe-Suzuki, Erica Yada, et al.
Japanese Journal of Clinical Oncology
|
February 10, 2022
Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab
Kosuke Ueda, Shigetaka Suekane, Hirofumi Kurose, et al.
The American Journal of Cardiology
|
December 27, 2005
Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome
Raisuke Iijima, Hideo Shinji, Nobutaka Ikeda, et al.
Cell Metabolism
|
May 8, 2026
Garlic-derived metabolite activates LKB1, promotes adipose eNAMPT secretion, and improves age-related muscle function via hypothalamic signaling
Jun-Ichiro Suzuki, Kiyoshi Yoshioka, Masahiro Kurita, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab
Naoki Ito, Kosuke Ueda, Satoshi Ohnishi, et al.
International Journal of Clinical Oncology
|
February 3, 2025
Therapeutic efficacy of immune-oncology combination therapy in advanced renal cell carcinoma without prior nephrectomy
Kosuke Ueda, Naoki Ito, Yuya Sakai, et al.
Anticancer Research
|
October 30, 2024
Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma
Kosuke Ueda, Naoki Ito, Yuya Sakai, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 147) with videos related to
Sort By:
Page
of 15
The Journal of Pediatrics
|
March 23, 2010
Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele
Akira Ohishi, Shigehiro Takahashi, Yushi Ito, et al.
Communications Biology
|
February 13, 2021
Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation
Keisuke Takeda, Aoi Uda, Mikihiro Mitsubori, et al.
Journal of Pediatric Surgery
|
December 1, 2009
Evaluating mortality and disease severity in congenital diaphragmatic hernia using the McGoon and pulmonary artery indices
Shigehiro Takahashi, Yoshihisa Oishi, Naoki Ito, et al.
Plos Currents
|
November 22, 2011
Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages
Bo Wang, Yuko Miyagoe-Suzuki, Erica Yada, et al.
Japanese Journal of Clinical Oncology
|
February 10, 2022
Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab
Kosuke Ueda, Shigetaka Suekane, Hirofumi Kurose, et al.
The American Journal of Cardiology
|
December 27, 2005
Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome
Raisuke Iijima, Hideo Shinji, Nobutaka Ikeda, et al.
Cell Metabolism
|
May 8, 2026
Garlic-derived metabolite activates LKB1, promotes adipose eNAMPT secretion, and improves age-related muscle function via hypothalamic signaling
Jun-Ichiro Suzuki, Kiyoshi Yoshioka, Masahiro Kurita, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab
Naoki Ito, Kosuke Ueda, Satoshi Ohnishi, et al.
International Journal of Clinical Oncology
|
February 3, 2025
Therapeutic efficacy of immune-oncology combination therapy in advanced renal cell carcinoma without prior nephrectomy
Kosuke Ueda, Naoki Ito, Yuya Sakai, et al.
Anticancer Research
|
October 30, 2024
Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma
Kosuke Ueda, Naoki Ito, Yuya Sakai, et al.
Page
of 15